Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fanhdi in Pediatric Subjects With Severe Von Willebrand Disease
NCT02472665Phase 4Withdrawn
- Sponsor
- Grifols
- Start
- Dec 2013
- Primary completion
- Dec 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of von willebrand factor + factor viii in von Willebrand disease (VWD), sponsored by Grifols. Planned start Dec 2013; status: withdrawn.
02
Drugs
von willebrand factor + factor viii
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT02472665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472665.